Marc Schaber

ORCID: 0000-0001-6523-8384
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Erythropoietin and Anemia Treatment
  • Travel-related health issues
  • Chronic Disease Management Strategies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Climate Change and Health Impacts
  • High Altitude and Hypoxia
  • Long-Term Effects of COVID-19
  • Iron Metabolism and Disorders
  • Respiratory Support and Mechanisms

Ordensklinikum Linz Barmherzige Schwestern
2020

UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik
2015

Background After the 2002/2003 severe acute respiratory syndrome outbreak, 30% of survivors exhibited persisting structural pulmonary abnormalities. The long-term sequelae coronavirus disease 2019 (COVID-19) are yet unknown, and comprehensive clinical follow-up data lacking. Methods In this prospective, multicentre, observational study, we systematically evaluated cardiopulmonary damage in subjects recovering from COVID-19 at 60 100 days after confirmed diagnosis. We conducted a detailed...

10.1183/13993003.03481-2020 article EN cc-by-nc European Respiratory Journal 2020-12-10

Infections with SARS-CoV-2 can result in severe clinical manifestations. As such patients present systemic inflammation, we studied the prevalence and predictive value of anemia inflammation (AI) or functional iron deficiency (FID), originating from immune-mediated alterations homeostasis. Within this retrospective analysis 259 hospitalized COVID-19, found that, upon admission, 24.7% were anemic, majority suffering AI (68.8%). Anemia was associated a significantly higher in-hospital...

10.3390/jcm9082429 article EN Journal of Clinical Medicine 2020-07-29

Introduction . The aim of the present study was to investigate whether a 12-hour exposure in normobaric hypoxic chamber would induce changes hemostatic system and procoagulant state volunteers suffering from acute mountain sickness (AMS) healthy controls. Materials Methods 37 participants were passively exposed 12.6% FiO 2 (simulated altitude hypoxia 4,500 m). AMS development investigated by Lake Louise Score (LLS). Prothrombin time, activated partial thromboplastin fibrinogen, platelet...

10.1155/2015/593938 article EN cc-by BioMed Research International 2015-01-01
Coming Soon ...